Systematic review: adverse events of fecal microbiota transplantation
S Wang, M Xu, W Wang, X Cao, M Piao, S Khan, F Yan… - PloS one, 2016 - journals.plos.org
Background Fecal microbiota transplantation (FMT) is a microbiota-based therapy that
shows therapeutic potential in recurrent or refractory Clostridium difficile infections and other …
shows therapeutic potential in recurrent or refractory Clostridium difficile infections and other …
Adverse events in faecal microbiota transplant: a review of the literature
M Baxter, A Colville - Journal of Hospital Infection, 2016 - Elsevier
Background Faecal microbiota transplant (FMT) is the infusion of donor faeces into the gut
with the aim of improving microbial diversity. The procedure has gained significant interest …
with the aim of improving microbial diversity. The procedure has gained significant interest …
Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement
Multidrug-resistant organism (MDRO) colonization is a fundamental challenge in
antimicrobial resistance. Limited studies have shown that fecal microbiota transplantation …
antimicrobial resistance. Limited studies have shown that fecal microbiota transplantation …
Fecal Microbiota Transplant for Treatment ofClostridium difficileInfection in Immunocompromised Patients
OBJECTIVES: Patients who are immunocompromised (IC) are at increased risk
ofClostridium difficileinfection (CDI), which has increased to epidemic proportions over the …
ofClostridium difficileinfection (CDI), which has increased to epidemic proportions over the …
[HTML][HTML] ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers
E Tacconelli, F Mazzaferri, AM de Smet… - Clinical microbiology …, 2019 - Elsevier
Scope The aim of these guidelines is to provide recommendations for decolonizing
regimens targeting multidrug-resistant Gram-negative bacteria (MDR-GNB) carriers in all …
regimens targeting multidrug-resistant Gram-negative bacteria (MDR-GNB) carriers in all …
Synergistic bacterial compositions and methods of production and use thereof
2014-04-08 Assigned to Seres Health, Inc. reassignment Seres Health, Inc. ASSIGNMENT
OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AFEYAN …
OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AFEYAN …
Compositions and methods
G McKenzie, MJL McKenzie, DN Cook, M Vulic… - US Patent …, 2015 - Google Patents
US9011834B1 - Compositions and methods - Google Patents US9011834B1 - Compositions
and methods - Google Patents Compositions and methods Download PDF Info Publication …
and methods - Google Patents Compositions and methods Download PDF Info Publication …
Synergistic bacterial compositions and methods of production and use thereof
US8906668B2 - Synergistic bacterial compositions and methods of production and use
thereof - Google Patents US8906668B2 - Synergistic bacterial compositions and methods …
thereof - Google Patents US8906668B2 - Synergistic bacterial compositions and methods …
A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients
O Shogbesan, DR Poudel, S Victor… - Canadian journal of …, 2018 - Wiley Online Library
Background. Fecal microbiota transplantation (FMT) has been shown to be effective in
recurrent Clostridium difficile (CD) infection, with resolution in 80% to 90% of patients …
recurrent Clostridium difficile (CD) infection, with resolution in 80% to 90% of patients …
Synergistic bacterial compositions and methods of production and use thereof
Mammals are colonized by microbes in the gastrointes tinal (GI) tract, on the skin, and in
other epithelial and tissue niches Such as the oral cavity, eye surface and vagina. The …
other epithelial and tissue niches Such as the oral cavity, eye surface and vagina. The …